Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care

Rukavina, Katarina; McConvey, Victor; Chaudhuri, К. Ray

doi:10.1016/bs.irn.2022.03.004

Cited by 2 publications

(2 citation statements)

References 71 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The study selection process is summarised in figure 1. Following the screening process, 58 of the 674 identified studies were considered for inclusion, and subsequently, a further 51 studies were excluded because they were not related to ACP,19–56 not review articles57–64 and encompassed pre-pandemic studies 65–69. Finally, we included seven studies—two systematic reviews,70 71 three scoping reviews,7 72 73 one narrative review74 and one critical realist review 75…”

Section: Resultsmentioning

confidence: 99%

Barriers to and facilitators of advance care planning implementation for medical staff after the COVID-19 pandemic: an overview of reviews

Inokuchi,

Hanari,

Shimada

et al. 2023

BMJ Open

View full text Add to dashboard Cite

ObjectiveThe COVID-19 pandemic has impacted the capacity for advance care planning (ACP) among patients, families and healthcare teams. We sought to identify and review the barriers to and facilitators of ACP implementation for medical staff in different settings (eg, hospitals, outpatient palliative care, nursing and care homes) during the pandemic.DesignThis study employed an overview of reviews design. We searched the MEDLINE, CENTRAL, Web of Science and Embase databases for studies published between 8 December 2019 and 30 July 2023. We used AMSTAR 2 to assess the risk of bias.ResultsWe included seven reviews. Common barriers to ACP implementation included visitation restrictions, limited resources and personnel and a lack of coordination among healthcare professionals. In care and nursing homes, barriers included a dearth of palliative care physicians and the psychological burden on facility staff. Using telemedicine for information sharing was a common facilitator across settings. In hospitals, facilitators included short-term training in palliative care and palliative care physicians joining the acute care team. In care and nursing homes, facilitators included ACP education and emotional support for staff.ConclusionsVisitation restrictions and limited resources during the pandemic posed obstacles; however, the implementation of ACP was further hindered by insufficient staff education on ACP in hospitals and facilities, as well as a scarcity of information sharing at the community level. These pre-existing issues were magnified by the pandemic, drawing attention to their significance. Short-term staff training programmes and immediate information sharing could better enable ACP.PROSPERO registration numberCRD42022351362.

show abstract

Section: Resultsmentioning

confidence: 99%

Barriers to and facilitators of advance care planning implementation for medical staff after the COVID-19 pandemic: an overview of reviews

Inokuchi,

Hanari,

Shimada

et al. 2023

BMJ Open

View full text Add to dashboard Cite

show abstract

“…Whether this pattern was deliberate or not remains unclear. The true frequency of COVID-19 among PD patients’ needs to be further explored in large studies with representative control groups in which cultural/ethnic diversity and local parameters (e.g., urban versus rural settings) will be accounted for [ 39 ].…”

Section: Is Covid-19 More Common Among Parkinson’s Disease Patients?mentioning

confidence: 99%

SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now

Boura,

Qamar,

Daddoveri

et al. 2023

Biomedicines

View full text Add to dashboard Cite

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has been discussed in the context of Parkinson’s disease (PD) over the last three years. Now that we are entering the long-term phase of this pandemic, we are intrigued to look back and see how and why the community of patients with PD was impacted and what knowledge we have collected so far. The relationship between COVID-19 and PD is likely multifactorial in nature. Similar to other systemic infections, a probable worsening of PD symptoms secondary to COVID-19, either transient or persistent (long COVID), has been demonstrated, while the COVID-19-related mortality of PD patients may be increased compared to the general population. These observations could be attributed to direct or indirect damage from SARS-CoV-2 in the central nervous system (CNS) or could result from general infection-related parameters (e.g., hospitalization or drugs) and the sequelae of the COVID-19 pandemic (e.g., quarantine). A growing number of cases of new-onset parkinsonism or PD following SARS-CoV-2 infection have been reported, either closely (post-infectious) or remotely (para-infectious) after a COVID-19 diagnosis, although such a link remains hypothetical. The pathophysiological substrate of these phenomena remains elusive; however, research studies, particularly pathology studies, have suggested various COVID-19-induced degenerative changes with potential associations with PD/parkinsonism. We review the literature to date for answers considering the relationship between SARS-CoV-2 infection and PD/parkinsonism, examining pathophysiology, clinical manifestations, vaccination, and future directions.

show abstract

Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care

Cited by 2 publications

References 71 publications

Barriers to and facilitators of advance care planning implementation for medical staff after the COVID-19 pandemic: an overview of reviews

Barriers to and facilitators of advance care planning implementation for medical staff after the COVID-19 pandemic: an overview of reviews

SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now

Contact Info

Product

Resources

About